CD276 and breast cancer: Therefore, the soluble form of B7-H3 present in serum has been proposed as a potential biomarker for breast cancer, capable of distinguishing patients with malignant lesions from both healthy individuals and those with benign breast lesions; however, the study evaluating the diagnostic potential of B7-H3 was limited by small study sample size [134].